Skip to main content
×
Home
    • Aa
    • Aa

Suicide in Bipolar Disorder: Risks and Management

Abstract
ABSTRACT

Bipolar disorders are prevalent, often severe, and disabling illnesses with elevated lethality largely due to suicide. Suicide rates average ∼1% annually, or perhaps 60 times higher than the international population rate of 0.015% annually. Suicidal acts typically occur early in bipolar disorders and in association with severe depressive or mixed states. The high lethality of suicidal acts in bipolar disorders is suggested by a much lower ratio of attempts:suicide (∼3:1) than in the general population (∼30:1). Risk factors can help to identify patients at increased suicidal risk, but ongoing clinical assessment is essential to limit risk. Empirical short-term interventions to manage acute suicidal risk include close clinical supervision, rapid hospitalization, and electroconvulsive therapy. Remarkably, however, evidence of the long-term effectiveness of most treatments against suicidal behavior is rare. A notable exception is lithium prophylaxis, which is associated with consistent evidence of major (∼80%), sustained relative reductions of risk of suicides and attempts, and lower lethality (increased attempts:suicide ratio). Such benefits are unproved for other treatments commonly used to treat bipolar disorder patients, including anticonvulsants, antipsychotics, antidepressants, and psychosocial interventions. Applying available knowledge systematically, with close and sustained clinical supervision, can enhance management of suicidal risk in bipolar disorders patients.

Copyright
Corresponding author
Please direct all correspondence to: Ross J. Baldessarini, MD, McLean Hospital, Mailman Research Center, Room 306, 115 Mill Street, Belmont, MA 02478-9106; Tel: 617-855-3203, Fax: 617-855-3479; E-mail: rib@mclean.org.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. L Tondo , G Isacsson , RJ Baldessarini . Suicidal behavior in bipolar disorder: risk and prevention. CNS Drugs. 2003;17:491511.

6. RC Kessler , WT Chiu , O Demler , KR Merikangas , EE Walters . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617627.

7. B Ahrens , B Müller-Oerlinghausen , M Schou , al et . Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord. 1995;33:6775.

8. EC Harris , B Barraclough . Suicide as an outcome for mental disorders: A meta-analysis. Br J Psychiatry. 1997;170:205228.

9. R Sharma , HR Markar . Mortality in affective disorder. J Affect Disord. 1994;31:9196.

10. K Hawton , E Arensman , D Wasserman , et al.Relations between attempted suicide and suicide rates among young people in Europe. J Epidemiol Community Health. 1998;52:191194.

11. RC Kessler , P Berglund , G Borges , M Nock , PS Wang . Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990–1992 to 2001–2003. JAMA. 2005;293:24872495.

12. FK Goodwin , B Fireman , GE Simon , EM Hunkeler , J Lee , D Revicki . Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:14671473.

13. SC Dilsaver , Y-W Chen , AC Swann , AM Shoaib , Y Tsai-Dilsaver , KJ Krajewski . Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure mania. Psychiatry Res. 1997;73:4756.

15. GL Faedda , RJ Baldessarini , T Suppes , L Tondo , I Becker , D Lipschitz . Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry. 1995;3:171195.

16. GW Blair-West , CH Cantor , GW Mellsop , ML Eyeson-Annan . Lifetime suicide risk in major depression: sex and age determinants. J Affect Disord. 1999;55:171178.

17. U Ösby , L Brandt , N Correia , A Ekbom , P Sparen . Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844850.

19. L Tondo , M Albert , RJ Baldessarini . Suicide rates in relation to health-care access in the United States. J Clin Psychiatry. 2006;67:517523.

20. L Tondo , RJ Baldessarini , J Hennen , G Floris , F Silvetti , M Tohen . Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry. 1998;59:405414.

22. M Arató , E Demeter , Z Rihmer , E Somogyi . Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr Scand. 1988;77:454456.

23. Z Rihmer , P Pestality . Bipolar II disorder and suicidal behavior. Psychiatr Clin North Am. 1999;22:667673.

24. SN Ghaemi , KJ Rosenquist , JY Ko , CF Baldassano , NJ Kontos , RJ Baldessarini : Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004;161:163165.

26. J Pirkis , P Burgess . Suicide and recency of health care contacts. A systematic review. Br J Psychiatry. 1998;173:462474.

27. UA Andersen , M Andersen , JU Rosholm , LF Gram . Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders. Acta Psychiatr Scand. 2001;104:458465.

28. CL Miller , B Druss . Datapoints: suicide and access to care. Psychiatr Serv. 2001;52:15661567.

29. RJ Baldessarini , L Tondo , J Hennen , AC Viguera : Is lithium still worth using? An update of selected recent research. Harv Rev Psychiatry. 2002;10:5975.

31. A Cipriani , H Pretty , K Hawton , JR Geddes . Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162:18051819.

33. B Müller-Oerlinghausen . Arguments for the specificity of the antisuicidal effect of lithium. Eur Arch Psychiatry Clin Neurosci. 2001;251(Suppl 2):7275.

34. B Ahrens . B Müller-Oerlinghausen . Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry. 2001;34:132136.

35. F Angst , HH Stassen , PJ Clayton , J Angst . Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68:167181.

36. D Waddington , IP McKenzie . Overdose rates in lithium-treated versus antidepressant-treated outpatients. Acta Psychiatr Scand. 1994;90:5052.

37. WA Watson , TL Litovitz , W Klein-Schwartz , et al.2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System (TESS). Am J Emerg Med. 2004;22:335404.

38. W Greil , N Kleindienst . The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol. 1999;14:277281.

39. CL Bowden , JR Calabrese , G Sachs , et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003;60:392400.

40. JR Calabrese , CL Bowden , G Sachs , et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003;64:10131024.

41. HY Meltzer , L Alphs , Al Green , et al.Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60:8291.

42. J Hennen , RJ Baldessarini . Suicidal risk during treatment with clozapine: a metaanalysis. Schizophr Res. 2005;73:139145.

43. J Modestin , D Dal Pian , P Agarwalla . Clozapine diminishes suicidal behavior: a retrospective evaluation of clinical records. J Clin Psychiatry. 2005;66:534538.

44. DM Gardner , RJ Baldessarini , P Waraich . Modern antipsychotic drugs: A critical overview. CMAJ. 2005;172:17031711.

45. MF Grunebaum , SP Ellis , S Li , MA Oquendo , JJ Mann . Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry. 2004;65:14561462.

46. T Helgason , H Tomasson , T Zoega . Antidepressants and public health in Iceland. Time series analysis of national data. Br J Psychiatry. 2004;184:157162.

47. RD Gibbons , K Hur , DK Bhaumik , JJ Mann . The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005;62:165172.

48. A Khan , S Khan , R Kolts , WA Brown . Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160:790792.

49. D Fergusson , S Doucette , KC Glass , et al.Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ. 2005;330:396403.

50. D Gunnell , J Saperia , D Ashby . Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA's safety review. BMJ. 2005;330:385388.

51. C Martinez , S Rietbrock , L Wise , et al.Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005;330:389396.

52. TA Hammad , T Laughren , L Racoosin . Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63:332339.

53. CM Beasley Jr, BE Dornseif , JC Bosomworth , et al.Fluoxetine and suicide: a metaanalysis of controlled trials of treatment for depression. BMJ. 1991;303:685692.

56. AG Pedersen . Escitalopram and suicidality in adult depression and anxiety. Int Clin Psychopharmacol. 2005;20:139143.

60. M Berk , S Dodd . Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression? Med Hypotheses. 2005;65:3943.

61. GL Faedda , RJ Baldessarini , IP Glovinsky , NB Austin . Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord. 2004;82:149158.

62. RJ Baldessarini , GL Faedda , J Hennen . Risk of mania with antidepressants. Arch Pediatr Adolesc Med. 2005;159:298299.

64. NA Huxley , SV Parikh , RJ Baldessarini . Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv Rev Psychiatry. 2000;8:126140.

66. MP Egan . Contracting for safety: a concept analysis. Crisis. 1997;18:1723.

67. A Nilsson . Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry. 1995;28:813.

68. J Angst , R Sellaro , F Angst . Long-term outcome and mortality of treated vs. untreated bipolar and depressed patients: a preliminary report. Int J Psychiatr Clin Practice. 1998;2:115119.

70. M Maj , F Starace , G Nolfe , D Kemali . Minimum plasma lithium levels required for effective prophylaxis in DSM-III bipolar disorder: a prospective study. Pharmacopsychiatry. 1986;19:420423.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 54 *
Loading metrics...

Abstract views

Total abstract views: 1382 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 28th June 2017. This data will be updated every 24 hours.